Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice-Reference-Cited by-同舟云学术

Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice

Published:2019 Issue:1 Volume:65 Page:34-46
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Ushiroda Chihiro¹,Naito Yuji¹,Takagi Tomohisa¹,Uchiyama Kazuhiko¹,Mizushima Katsura¹,Higashimura Yasuki²,Yasukawa Zenta³,Okubo Tsutomu³,Inoue Ryo⁴,Honda Akira⁵,Matsuzaki Yasushi⁵,Itoh Yoshito¹

Affiliation:

1. Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

2. Department of Food Science, Ishikawa Prefectural University

3. Nutrition Division, Taiyo Kagaku Co. Ltd.

4. Laboratory of Animal Science, Department of Agricultural and Life Sciences, Kyoto Prefectural University

5. Gastroenterology, Tokyo Medical University Ibaraki Medical Center

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.jstage.jst.go.jp/article/jcbn/65/1/65_18-116/_pdf

Reference54 articles.

1. 1 Hashimoto E, Taniai M, Tokushige K. Characteristics and diagnosis of NAFLD/NASH. J Gastroenterol Hepatol 2013; 28: 64–70.

2. 2 Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut 2019; 68: 359–370.

3. 3 Mouzaki M, Bandsma R. Targeting the gut microbiota for the treatment of non-alcoholic fatty liver disease. Curr Drug Targets 2015; 16: 1324–1331.

4. 4 Saltzman ET, Palacios T, Thomsen M, Vitetta L. Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease. Front Microbiol 2018; 9: 61.

5. 5 Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009; 137: 1716–1724.

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TFEB activator tanshinone IIA and derivatives derived from Salvia miltiorrhiza Bge. Attenuate hepatic steatosis and insulin resistance;Journal of Ethnopharmacology;2024-12

2. Effects of dietary protein level on liver lipid deposition, bile acid profile and gut microbiota composition of growing pullets;Poultry Science;2024-11

3. Effect of Phenolic Compounds on Intestinal Health in Preclinical Models of Diet-Induced Obesity: A Systemic Review;Food Reviews International;2024-07-24

4. Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review;Food Science & Nutrition;2024-06-07

5. Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation;Journal of Agricultural and Food Chemistry;2024-04-12